Background: Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence ...

Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence supporting its ...

According to GlobalData, the worldwide thrombectomy device market was worth $2.96 billion in 2024 and is set to register a ...

Background: Percutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid ...

Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana thrombectomy system in treating acute pulmonary embolism (PE) patients.

Credit: CGN089/Shutterstock. Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana thrombectomy system in treating acute pulmonary ...

a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolism (VTE), announced that the first patient was enrolled in the QUADRA-PE study evaluating the ...

The primary uses of thrombectomy devices include the treatment of ischemic stroke (the leading cause of morbidity and mortality worldwide), pulmonary embolism, and deep vein thrombosis. With the ...

Stryker has completed its $4.9 billion acquisition of Inari Medical, a company specializing in venous thromboembolism ...